These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11352032)

  • 1. Science and society.
    May RM
    Science; 2001 May; 292(5519):1021. PubMed ID: 11352032
    [No Abstract]   [Full Text] [Related]  

  • 2. Britain opens biotech regulation to greater public involvement.
    Masood E
    Nature; 1999 May; 399(6734):287-8. PubMed ID: 10360555
    [No Abstract]   [Full Text] [Related]  

  • 3. Yes, Prime Minister: be open about the science, but don't expect an easy ride.
    New Sci; 2002 Jun; 174(2345):5. PubMed ID: 12374173
    [No Abstract]   [Full Text] [Related]  

  • 4. The legacy of nuclear risk and the founder effect in biotechnology organizations.
    Fleising U
    Trends Biotechnol; 2002 Apr; 20(4):156-9. PubMed ID: 11906747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't keep secrets. There's no alternative to being open with the public.
    New Sci; 2000 Mar; 165(2230):3. PubMed ID: 11885639
    [No Abstract]   [Full Text] [Related]  

  • 6. Trials, tribulations and diversification.
    Nat Biotechnol; 2003 Dec; 21(12):1411. PubMed ID: 14647307
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Bioethics needs better input from public'.
    Butler D
    Nature; 1997 Oct; 389(6653):775. PubMed ID: 9349797
    [No Abstract]   [Full Text] [Related]  

  • 8. The public's role in science policy.
    Zinser J
    Am J Bioeth; 2005; 5(6):58-60; discussion W14-6. PubMed ID: 16282117
    [No Abstract]   [Full Text] [Related]  

  • 9. Asilomar revisited: lessons for today?
    Barinaga M
    Science; 2000 Mar; 287(5458):1584-5. PubMed ID: 10766605
    [No Abstract]   [Full Text] [Related]  

  • 10. What we know and what we don't about cloning and society.
    Franklin S
    New Genet Soc; 1999; 18(1):111-20. PubMed ID: 17256207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Designing Genopole, a new concept and actor for science, technology and innovation policy in France].
    Branciard A
    Med Sci (Paris); 2009 May; 25 Spec No 2():9-12. PubMed ID: 19852085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blair supports science.
    Connelly R
    Lab Anim (NY); 2002; 31(7):12-3. PubMed ID: 14619842
    [No Abstract]   [Full Text] [Related]  

  • 13. Creating public alienation: expert cultures of risk and ethics on GMOs.
    Wynne B
    Sci Cult (Lond); 2001 Dec; 10(4):445-81. PubMed ID: 15971363
    [No Abstract]   [Full Text] [Related]  

  • 14. About audience-specific communication.
    Burlon O
    Biotechnol J; 2007 Sep; 2(9):1070-1. PubMed ID: 17722182
    [No Abstract]   [Full Text] [Related]  

  • 15. Time to drop the language of 'consensus'.
    Turner L
    Nat Biotechnol; 2003 Dec; 21(12):1433. PubMed ID: 14647320
    [No Abstract]   [Full Text] [Related]  

  • 16. Slouching toward policy: lazy bioethics and the perils of science fiction.
    Guyer RL; Moreno JD
    Am J Bioeth; 2004; 4(4):W14-7. PubMed ID: 16192175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabinet reshuffle demotes British science.
    Dean M
    Lancet; 1995 Jul; 346(8969):238. PubMed ID: 7616806
    [No Abstract]   [Full Text] [Related]  

  • 18. Vox populi and public policy: why should we care?
    Miller HI
    Nat Biotechnol; 2003 Dec; 21(12):1431-2. PubMed ID: 14647319
    [No Abstract]   [Full Text] [Related]  

  • 19. Expert discourses of risk and ethics on genetically manipulated organisms: the weaving of public alienation.
    Wynne B
    Not Polit; 2001; 17(62):51-76. PubMed ID: 15468486
    [No Abstract]   [Full Text] [Related]  

  • 20. Public bioethics and public engagement: the politics of "proper talk".
    Moore A
    Public Underst Sci; 2010 Mar; 19(2):197-211. PubMed ID: 20533798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.